已收盤 04-02 16:00:00 美东时间
-0.660
-0.89%
US Physical Therapy (NYSE:USPH) reported quarterly earnings of $0.67 per share which met the analyst consensus estimate. This is a 31.37 percent increase over earnings of $0.51 per share from the same period last year.
02-26 14:33
Companies Reporting Before The Bell • Clear Secure (NYSE:YOU) is expected to re...
02-25 19:11
今日重点评级关注:HC Wainwright & Co.:维持Ardelyx"买入"评级,目标价从10美元升至18美元;Truist Securities:维持Praxis Precision Medicine"买入"评级,目标价从500美元升至700美元
02-23 08:56
Barrington Research analyst Michael Petusky maintains US Physical Therapy (NYSE:USPH) with a Outperform and maintains $103 price target.
02-20 20:59
U.S. Physical Therapy, Inc. ("USPH") (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced a 10-year strategic alliance
02-02 20:35
今日重点评级关注:HC Wainwright & Co.:维持Assertio Holdings"买入"评级,目标价从3美元升至35美元;HC Wainwright & Co.:维持万达生物制药"买入"评级,目标价从20美元升至22美元
01-06 17:52
Barrington Research analyst Michael Petusky maintains US Physical Therapy (NYSE:USPH) with a Outperform and maintains $103 price target.
01-05 23:31
U.S. Physical Therapy, Inc. ("USPH" or the "Company") (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced the acquisition
01-05 20:35
今日重点评级关注:巴克莱:维持Iovance Biotherapeutics"超配"评级,目标价从4美元升至9美元;BTIG:维持Cullinan Therapeutics"买入"评级,目标价从32美元升至38美元
2025-11-25 10:27
JP Morgan analyst Benjamin Rossi maintains US Physical Therapy (NYSE:USPH) with a Overweight and lowers the price target from $110 to $100.
2025-11-24 23:30